Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-779,180.60
% of Total Estimate Gain
-11.48%

Springhill Fund Asset Management (HK) Co Ltd's Cytokinetics Inc Holding Summary

As of 2025-03-31, Springhill Fund Asset Management (HK) Co Ltd held - shares of Cytokinetics Inc(CYTK), totaling N/A. This investment constitutes 0% of their stock portfolio, and Springhill Fund Asset Management (HK) Co Ltd now holds 0% of the outstanding Cytokinetics Inc(CYTK) stock.

The initial trade took place in 2024Q4. In addition, there have been 1 sales at an average price of $45.96 for 130,735.00 shares. Based on historical transaction data and CYTK's current price of $33.36, Springhill Fund Asset Management (HK) Co Ltd's estimated gain on his CYTK holdings is $-779,180.60, reflecting a -11.48% gain to date.

Springhill Fund Asset Management (HK) Co Ltd CYTK ($33.36) Holding Chart

Springhill Fund Asset Management (HK) Co Ltd CYTK ($33.36) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1